Vaccine breakthrough cases in Oregon by variant to 16th September 2021

Vaccine breakthrough data for Oregon state by Sars-CoV-2 variant up to 16th September 2021.

The Delta variant is currently responsible for the majority of vaccine breakthrough cases in Oregon. Oregon state is currently sequencing about 5% of their case samples.

 

Vaccine breakthroughs in Oregon to 16 September 2021. The cumulative total is now 19,549 breakthrough cases.

16th Sept 2021

Variant
LineageNumber of Vaccine
Breakthrough Cases
With Variant
Increase in
Number of
Breakthroughs
From Previous
Week
AlphaB.1.1.71400
GammaP.1471
EpsilonB.1.427/429380
DeltaB.1.617.2690111
IotaB.1.526290
BetaB.1.351160
SequencedSequenced960112
Weekly Total of all VB casesWeekly Total of all VB cases2632-242

 

Vaccine breakthroughs in Oregon to 09 September 2021. The cumulative total is now 16,417 breakthrough cases.

9th Sept 2021

Variant
LineageNumber of Vaccine
Breakthrough Cases
With Variant
AlphaB.1.1.7140
GammaP.146
EpsilonB.1.427/42938
DeltaB.1.617.2579
IotaB.1.52629
BetaB.1.35116
SequencedSequenced848
Weekly Total of all VB casesWeekly Total of all VB cases2874

 

Source: Oregon Vaccine Breakthrough file

 

 

 

 

Image by jacobdeb from Pixabay

USA: 55% increase in Delta vaccine breakthrough cases in Washington State

This week’s update from Washington State showing vaccine breakthrough cases and which Sars-CoV-2 variant is causing them up to 11th August 2021. Of note this week is another big jump for Delta B.1.617.2 vaccine breakthrough cases, which have increased by 55% from 405 to 629 in one week.  There is also a sudden and rather alarming 74% increase in vaccine breakthrough cases where the Sars-CoV-2 variant is defined as “other”.

** There is an UPDATE of this post here **

Vaccine Breakthroughs up to 11th August 2021

11th August 2021

Variant
LineageNumber of Vaccine
Breakthrough Cases
With Variant
Percentage of Vaccine
Breakthrough Cases With
Variant
Percentage of
Sequences From
All Covid-19
Cases With
Variant
Increase in
Number of
Breakthroughs
From Previous
Week
DeltaB.1.617.262944%12%224
AlphaB.1.1.735225%39%9
GammaP.118213%9%7
EpsilonB.1.4291168%14%0
IotaB.1.526282%3%1
EpsilonB.1.427111%2%0
BetaB.1.351101%1%0
EtaB.1.52540%0%0
KappaB.1.617.110%0%0
OtherOther876%20%37
TotalTotal1420100%100%278

Vaccine Breakthroughs up to 4th August 2021

4th August 2021

Variant
LineageNumber of Vaccine
Breakthrough Cases
With Variant
Percentage of Vaccine
Breakthrough Cases With
Variant
Percentage of
Sequences From
All Covid-19
Cases With
Variant
Increase in
Number of
Breakthroughs
From Previous
Week
DeltaB.1.617.240535%10%151
AlphaB.1.1.734330%41%6
GammaP.117515%9%7
EpsilonB.1.42911610%15%0
IotaB.1.526272%3%1
EpsilonB.1.427111%2%0
BetaB.1.351101%1%0
EtaB.1.52540%0%0
KappaB.1.617.110%0%0
OtherOther504%19%-4
Total1142100%100%161

Vaccine Breakthroughs up to 28th July 2021

28th July 2021

Variant
LineageNumber of Vaccine
Breakthrough Cases
With Variant
Percentage of Vaccine
Breakthrough Cases With
Variant
Percentage of
Sequences From
All Covid-19
Cases With
Variant
Increase in
Number of
Breakthroughs
From Previous
Week
AlphaB.1.1.733734%43%29
GammaP.116817%10%12
EpsilonB.1.42911612%15%3
DeltaB.1.617.225426%7%141
IotaB.1.526263%3%4
BetaB.1.351101%1%0
EpsilonB.1.427111%2%0
EtaB.1.52540%0%0
KappaB.1.617.110%0%0
ZetaP.200%0%0
OtherOther546%18%4
Total981100%100%193

Vaccine Breakthroughs up to 21st July 2021

21st July 2021

Variant
LineageNumber of Vaccine
Breakthrough Cases
With Variant
Percentage of Vaccine
Breakthrough Cases With
Variant
Percentage of
Sequences From
All Covid-19
Cases With
Variant
Increase in
Number of
Breakthroughs
From Previous
Week
AlphaB.1.1.730839%44%-1
GammaP.115620%10%9
EpsilonB.1.42911314%16%0
DeltaB.1.617.211314%4%23
IotaB.1.526223%3%0
BetaB.1.351101%1%-1
EpsilonB.1.427111%2%0
EtaB.1.52541%0%0
KappaB.1.617.110%0%0
ZetaP.200%0%0
OtherOther506%19%0
Total788100%100%30

Vaccine Breakthroughs up to 14th July 2021

14th July 2021

Variant
LineageNumber of Vaccine
Breakthrough Cases
With Variant
Percentage of Vaccine
Breakthrough Cases With
Variant
Percentage of
Sequences From
All Covid-19
Cases With
Variant
Increase in
Number of
Breakthroughs
From Previous
Week
AlphaB.1.1.730941%44%12
GammaP.114719%10%6
EpsilonB.1.42911315%16%0
DeltaB.1.617.29012%4%20
IotaB.1.526223%3%1
BetaB.1.351111%1%0
EpsilonB.1.427111%2%0
EtaB.1.52541%0%0
KappaB.1.617.110%0%0
ZetaP.200%0%0
OtherOther496%20%0
Total757100%100%39

Vaccine Breakthroughs up to 7th July 2021

7th July 2021

Variant
LineageNumber of Vaccine
Breakthrough Cases
With Variant
Percentage of Vaccine
Breakthrough Cases With
Variant
Percentage of
Sequences From
All Covid-19
Cases With
Variant
Increase in
Number of Breakthroughs
From Previous
Week
AlphaB.1.1.729741%44%11
GammaP.113919%9%6
EpsilonB.1.42911316%16%0
DeltaB.1.617.27010%4%30
IotaB.1.526213%3%7
BetaB.1.351112%1%1
EpsilonB.1.427112%2%0
EtaB.1.52541%0%0
KappaB.1.617.110%0%0
ZetaP.200%0%0
Other497%20%0
Total716100%100%55

Vaccine Breakthroughs up to 30th June 2021

30th June 2021

Variant
LineageNumber of Vaccine
Breakthrough Cases
With Variant
Percentage of Vaccine
Breakthrough Cases With
Variant
Percentage of
Sequences From
All Covid-19
Cases With
Variant
AlphaB.1.1.728637%38%
GammaP.113317%8%
EpsilonB.1.42911315%14%
DeltaB.1.617.2405%2%
IotaB.1.526142%3%
BetaB.1.351101%1%
EpsilonB.1.427111%2%
EtaB.1.52541%0%
KappaB.1.617.110%0%
ZetaP.200%0%
Other4921%32%
Totals661100%100%

 

 

Image by Frank Ravizza from Pixabay

USA: Washington State Vaccine Breakthroughs by Variant up to 21st July 2021

This week’s update from Washington State showing vaccine breakthrough cases and which Sars-CoV-2 variant is causing them. Of note this week is another large jump for Delta B.1.617.2 breakthrough cases, and a further increase for Gamma P1 breakthroughs.

Vaccine Breakthroughs up to 21st July 2021

21st July 2021

Variant
LineageNumber of Vaccine
Breakthrough Cases
With Variant
Percentage of Vaccine
Breakthrough Cases With
Variant
Percentage of
Sequences From
All Covid-19
Cases With
Variant
Increase in
Number of
Breakthroughs
From Previous
Week
AlphaB.1.1.730839%44%-1
GammaP.115620%10%9
EpsilonB.1.42911314%16%0
DeltaB.1.617.211314%4%23
IotaB.1.526223%3%0
BetaB.1.351101%1%-1
EpsilonB.1.427111%2%0
EtaB.1.52541%0%0
KappaB.1.617.110%0%0
ZetaP.200%0%0
OtherOther506%19%0
Total788100%100%30

Vaccine Breakthroughs up to 14th July 2021

14th July 2021

Variant
LineageNumber of Vaccine
Breakthrough Cases
With Variant
Percentage of Vaccine
Breakthrough Cases With
Variant
Percentage of
Sequences From
All Covid-19
Cases With
Variant
Increase in
Number of
Breakthroughs
From Previous
Week
AlphaB.1.1.730941%44%12
GammaP.114719%10%6
EpsilonB.1.42911315%16%0
DeltaB.1.617.29012%4%20
IotaB.1.526223%3%1
BetaB.1.351111%1%0
EpsilonB.1.427111%2%0
EtaB.1.52541%0%0
KappaB.1.617.110%0%0
ZetaP.200%0%0
OtherOther496%20%0
Total757100%100%39

USA: vaccine breakthough cases in Washington State by coronavirus variant to 30th June 2021

Washington State has recently published an update on the number of vaccine breakthrough cases. Importantly, it shows which Sars-CoV-2 variant is responsible for 661 of those cases through genome sequencing. This hugely important information is not available for most states in the USA, so the fact that Washington State continues to publish this information for the Covid variants currently circulating in that state makes it all the more valuable.  Spoiler alert: Delta B.1.617.2 is NOT YET the most common variant for vaccine breakthrough cases in Washington State! That situation will almost certainly change over the next few weeks as Delta becomes more dominant across the U.S.

The most common variant currently causing vaccine breakthroughs in Washington State up to 30th June 2021 is Alpha, (B.1.1.7),  at 37%, followed by Gamma (P.1) at 17%. The Delta variant (B.1.617.2) currently only accounts for about 5% of vaccine breakthrough infections.

The Epsilon variant (B.1.429) is showing as being responsible for 15% of all breakthrough cases, yet represents just 3% of the total genome sequences for May to June, and never rose above 10% of genome samples from April 2021.

Washington State data on all breakthrough cases:

Source: Washington State Vaccine Breakthrough Report

 

Sars-CoV-2 variants circulating in Washington State April – June 2021:

 

Source: Washington Covid-19 Dashboard

As you can see, Washington State has recorded 2,228 vaccine breakthrough cases in total which represents a tiny fraction of the 6 million people now vaccinated in that state.

Our thanks to The Washington State Department of Health for providing this vital information.

 

USA: Washington State Vaccine Breakthroughs by Variant up to 14th July 2021

 

USA: Washington State Vaccine Breakthroughs by Variant up to 7th July 2021

 

Israel: 50% vaccine breakthrough for coronavirus cases in the last month

Delta coronavirus variant now dominant in the USA

The highly transmissible Delta variant is the most common strain of the Covid-19 virus circulating in the U.S., new data shows.  An analysis of genetic sequencing data as of June 27 showed that the Delta strain, also known as B.1.617.2, now makes up about 40% of positive Covid-19 test samples.

Wall Street Journal report

** Outbreak.info is showing that the Delta variant has risen to about 47% in the last three weeks.

Chart courtesy of Outbreak.info

 

 

Image by Ronile from Pixabay

WHO announce new names for Sars-CoV-2 #coronavirus variants

The WHO have announced new names for the confusingly named sars-cov-2 variants. The new names are based on the Greek alphabet.

Variants of Concern = Alpha, Beta, Gamma, Delta

 

Variants of Interest = Epsilon, Zeta, Eta, Theta, Iota, Kappa

 

WHO introduces new naming system for Sars-CoV-2 variants based on Greek alphabet –  Alpha, Beta, Gamma, Delta, Epsilon, Zeta, Eta, Theta, Iota, Kappa etc

NEJM “a recombination event between B.1.1.7 and B.1.526” #coronavirus variants

Examination of the SARS-CoV-2 sequences revealed that both patients were infected with variant viruses. Rapid identification of sequence variants by targeted PCR amplification showed that neither sequence precisely fit any known clade. Some of the substitutions in Patient 1 (T95I, del144, E484K, A570D, D614G, P681H, and D796H) were shared with B.1.526 (T95I, E484K, and D614G6), and three substitutions were shared with Patient 2 (in whom the variants T95I, G142V and del144, F220I, R190T, R237K, R246T, and D614G were detected). Whole viral genome sequencing revealed several additional substitutions, including D796H, present in a guanine–cytosine–rich region not identified by targeted PCR. These substitutions may decrease sensitivity to convalescent serum11 and may have some unique noncoding changes as compared with the clades first identified in Wuhan, the United Kingdom, and New York City.

Although more detailed analysis of whole-genome sequencing from Patient 1 was undertaken, we could not conclude that the variant in this patient was a Pango lineage because it was only present in a single person.

Its closest links on the phylogenetic tree were the variant first identified in the United Kingdom (B.1.1.7) and the variant first identified in New York City (B.1.526), but with considerable differences. It will be of interest to determine whether this may have resulted from a recombination event between B.1.1.7 and B.1.526, as has been recently reported for recombination between the B.1.1.7 lineage and the “wild-type” lineage first identified in Wuhan. Alternatively, shared substitutions may be the result of convergent evolution.

NEJM: Vaccine Breakthrough Infections with SARS-CoV-2 Variants

 

See also:

NEJM: In two #coronavirus vaccine breakthrough cases “examination of the SARS-CoV-2 sequences revealed that both patients were infected with variant viruses” .. “neither sequence precisely fit any known clade”

NEJM: In two #coronavirus vaccine breakthrough cases “examination of the SARS-CoV-2 sequences revealed that both patients were infected with variant viruses” .. “neither sequence precisely fit any known clade”

Examination of the SARS-CoV-2 sequences revealed that both patients were infected with variant viruses. Rapid identification of sequence variants by targeted PCR amplification showed that neither sequence precisely fit any known clade. Some of the substitutions in Patient 1 (T95I, del144, E484K, A570D, D614G, P681H, and D796H) were shared with B.1.526 (T95I, E484K, and D614G6), and three substitutions were shared with Patient 2 (in whom the variants T95I, G142V and del144, F220I, R190T, R237K, R246T, and D614G were detected).

NEJM article  “Vaccine Breakthrough Infections with SARS-CoV-2 Variants”

 

Image by Daniel Roberts from Pixabay